Home › Myasthenia Gravis › California › San Francisco
Myasthenia Gravis clinical trials in San Francisco, CA
5 studies for Myasthenia Gravis are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecruitingPhase 3
- Site Number - 1004, San Francisco
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
RecruitingPhase 2/3
- UCSF Benioff Children's Hospital, San Francisco
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
RecruitingPhase 1/2
- University of California, San Francisco, San Francisco
Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
RecruitingObservational studyHealthy volunteers welcome
- University of California-San Francisco, San Francisco
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
RecruitingObservational study
- UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,, San Francisco
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL11 studies
- Houston, TX10 studies
- Durham, NC8 studies
- Columbus, OH8 studies
- Boca Raton, FL8 studies
- Milwaukee, WI7 studies
- Washington, DC6 studies
- Detroit, MI6 studies
- Miami, FL6 studies
- New York City, NY6 studies
- Philadelphia, PA6 studies
- Portland, OR6 studies
Other studies in San Francisco
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Non-Small Cell Lung Cancer37 studies
- Heart Failure29 studies
- Metastatic Cancer25 studies
- Lung Cancer23 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Cardiovascular Disease20 studies
- Pancreatic Cancer19 studies
- Glioblastoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.